We are super excited to introduce you to Sam Murdie. K9MD’s Senior Canine Trainer. Sam has extensive canine scent detection experience. Personally Sam has gained the title of Obedience …
We are proud to announce K9MD has won a global competition from the Royal Canin Foundation, based in France. We are extremely grateful to both Royal Canin and …
We have an exciting opportunity for a new senior canine trainer to join K9 Medical Detection NZ. based in Mosgiel, Dunedin. Medical Detection dogs are a valuable diagnostic …
We are absolutely thrilled to announce support for K9MD from Gilmour Motors and Suzuki New Zealand. Emma Gilmour is a passionate supporter of K9MD and our new formal partnership …
We are excited to introduce you to a new specialist nurse from Wellington joining K9MD. Gabrielle (Gabby) works as a Practice Nurse at Wakefield Gastroenterology Centre in Wellington. She …
We are extremely thankful to the trustees of the Grassroots Trust for their kind support. Together we can make a difference.
K9MD Hunter has completed his Proof-of-Concept validation for the detection of Ovarian cancer. Hunter checked 300 samples over 4 days in a blind randomized trial designed and analysed by …
We are thrilled to announce the support of the David Levene Foundation. K9MD relies solely on the kindness and generosity of the community, foundations, charitable trusts, businesses and philanthropists …
The 18th Annual Peter Brock Memorial Cruise was held on Sunday September 08th. The event is to celebrate the life of Peter Brock whilst raising funds for a charity …
The K9MD Team are thrilled to announce the results of a recent Proof of Concept validation for the detection of Ovarian cancer. This is a blind randomised trial designed …
We are extremely grateful to the board of trustees of the ILT Foundation continuing their support to K9MD. Our Invercargill nurses are crucial to the success of K9MD working …
The K9MD Team are thrilled to announce the results of a recent Proof of Concept validation for the detection of Bowel cancer. This is a blind randomised trial designed …
